Diabetes-Induced Inflammation and Vascular Alterations in the Goto–Kakizaki Rat Retina

References

• Arden GB, Sivaprasad S. The pathogenesis of early retinal changes of diabetic retinopathy. Doc Ophthalmol. 2012;124(1):15–26. doi:10.1007/s10633-011-9305-y.
   PubMed Web of Science ®Google Scholar
• Wilkinson-Berka JL. Angiotensin and diabetic retinopathy. Int J Biochem Cell Biol. 2006;38(5–6):752–65. doi:10.1016/j.biocel.2005.08.002.
   PubMed Web of Science ®Google Scholar
• Schultze JL, Schmieder A, Goerdt S. Macrophage activation in human diseases. Semin Immunol. 2015;27(4):249–56. doi:10.1016/j.smim.2015.07.003.
   PubMed Web of Science ®Google Scholar
• Hachana S, Bhat M, Senecal J, Huppe-Gourgues F, Couture R, Vaucher E. Expression, distribution and function of kinin B1 receptor in the rat diabetic retina. Br J Pharmacol. 2018;175(6):968–83. doi:10.1111/bph.v175.6.
   PubMed Web of Science ®Google Scholar
• Altmann C, Schmidt MHH. The role of microglia in diabetic retinopathy: inflammation, microvasculature defects and neurodegeneration. Int J Mol Sci. 2018;19(1):pii: E110. doi:10.3390/ijms19010110.
   PubMed Web of Science ®Google Scholar
• Grigsby JG, Cardona SM, Pouw CE, Muniz A, Mendiola AS, Tsin AT, Allen DM, Cardona AE. The role of microglia in diabetic retinopathy. J Ophthalmol. 2014;2014:705783.
   PubMed Web of Science ®Google Scholar
• Kimura K, Toyota T, Kakizaki M, Kudo M, Takebe K, Goto Y. Impaired insulin secretion in the spontaneous diabetes rats. Tohoku J Exp Med. 1982;137(4):453–59. doi:10.1620/tjem.137.453.
   PubMed Web of Science ®Google Scholar
• Goto A. [Serum immunoreactive insulin after the oral administration of single dose of tolbutamide. II. Pancreatic vein immunoreactive insulin in dogs (author’s transl)]. Nihon Naibunpi Gakkai Zasshi. 1975;51(8):685–92. doi:10.1507/endocrine1927.51.8_685.
   PubMedGoogle Scholar
• Portha B, Serradas P, Bailbe D, Suzuki K, Goto Y, Giroix MH. Beta-cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes. 1991;40(4):486–91. doi:10.2337/diab.40.4.486.
   PubMed Web of Science ®Google Scholar
• Karahashi M, Hirata-Hanta Y, Kawabata K, Tsutsumi D, Kametani M, Takamatsu N, Sakamoto T, Yamazaki T, Asano S, Mitsumoto A, et al. Abnormalities in the metabolism of fatty acids and triacylglycerols in the liver of the Goto-Kakizaki rat: a model for non-obese type 2 diabetes. Lipids. 2016;51(8):955–71. doi:10.1007/s11745-016-4171-8.
   PubMed Web of Science ®Google Scholar
• Carmo A, Cunha-Vaz JG, Carvalho AP, Lopes MC. Nitric oxide synthase activity in retinas from non-insulin-dependent diabetic Goto-Kakizaki rats: correlation with blood-retinal barrier permeability. Nitric Oxide. 2000;4(6):590–96. doi:10.1006/niox.2000.0312.
   PubMed Web of Science ®Google Scholar
• Takeo-Goto S, Doi M, Ma N, Goto R, Semba R, Uji Y. Immunohistochemical localization of amino acids in the diabetic retina of Goto-Kakizaki rats. Ophthalmic Res. 2002;34:139–45.
   PubMed Web of Science ®Google Scholar
• Fernandes R, Suzuki K, Kumagai AK. Inner blood-retinal barrier GLUT1 in long-term diabetic rats: an immunogold electron microscopic study. Invest Ophthalmol Vis Sci. 2003;44(7):3150–54. doi:10.1167/iovs.02-1284.
   PubMed Web of Science ®Google Scholar
• Matsubara H, Kuze M, Sasoh M, Ma N, Furuta M, Uji Y. Time-dependent course of electroretinograms in the spontaneous diabetic Goto-Kakizaki rat. Jpn J Ophthalmol. 2006;50(3):211–16. doi:10.1007/s10384-005-0315-8.
   PubMed Web of Science ®Google Scholar
• Omri S, Behar-Cohen F, de Kozak Y, Sennlaub F, Verissimo LM, Jonet L, Savoldelli M, Omri B, Crisanti P. Microglia/macrophages migrate through retinal epithelium barrier by a transcellular route in diabetic retinopathy: role of PKCzeta in the Goto Kakizaki rat model. Am J Pathol. 2011;179(2):942–53. doi:10.1016/j.ajpath.2011.04.018.
   PubMed Web of Science ®Google Scholar
• Fan Y, Liu K, Wang Q, Ruan Y, Zhang Y, Ye W. Exendin-4 protects retinal cells from early diabetes in Goto-Kakizaki rats by increasing the Bcl-2/Bax and Bcl-xL/Bax ratios and reducing reactive gliosis. Mol Vis. 2014;20:1557–68.
   PubMed Web of Science ®Google Scholar
• Gong CY, Lu B, Sheng YC, Yu ZY, Zhou JY, Ji LL. The development of diabetic retinopathy in Goto-Kakizaki rat and the expression of angiogenesis-related signals. Chin J Physiol. 2016;59(2):100–08. doi:10.4077/CJP.2016.BAE383.
   PubMed Web of Science ®Google Scholar
• Omri S, Behar-Cohen F, Rothschild PR, Gelize E, Jonet L, Jeanny JC, Omri B, Crisanti P. PKCzeta mediates breakdown of outer blood-retinal barriers in diabetic retinopathy. PLoS One. 2013;8(11):e81600. doi:10.1371/journal.pone.0081600.
   PubMed Web of Science ®Google Scholar
• Miyamoto K, Ogura Y, Nishiwaki H, Matsuda N, Honda Y, Kato S, Ishida H, Seino Y. Evaluation of retinal microcirculatory alterations in the Goto-Kakizaki rat. A spontaneous model of non-insulin-dependent diabetes. Invest Ophthalmol Vis Sci. 1996;37:898–905.
   PubMed Web of Science ®Google Scholar
• Al-Latayfeh M, Silva PS, Sun JK, Aiello LP. Antiangiogenic therapy for ischemic retinopathies. Cold Spring Harb Perspect Med. 2012;2(6):a006411. doi:10.1101/cshperspect.a006411.
   PubMed Web of Science ®Google Scholar
• Pouliot M, Talbot S, Senecal J, Dotigny F, Vaucher E, Couture R. Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats. PLoS One. 2012;7(3):e33864. doi:10.1371/journal.pone.0033864.
   PubMed Web of Science ®Google Scholar
• Penn JS, Tolman BL, Lowery LA. Variable oxygen exposure causes preretinal neovascularization in the newborn rat. Invest Ophthalmol Vis Sci. 1993;34:576–85.
   PubMed Web of Science ®Google Scholar
• Kengkoom K, Klinkhamhom A, Sirimontaporn A, Singha O, Ketjareon T, Panavechkijkul Y, Seriwatanachai D, Ukong S, Ampawong S. Effects on high cholesterol-fed to liver, retina, hippocampus, and Harderian gland in Goto-Kakizaki rat. Int J Clin Exp Pathol. 2013;6:639–49.
   PubMed Web of Science ®Google Scholar
• Quan Y, Du J, Wang X. High glucose stimulates GRO secretion from rat microglia via ROS, PKC, and NF-kappaB pathways. J Neurosci Res. 2007;85(14):3150–59. doi:10.1002/jnr.21421.
   PubMed Web of Science ®Google Scholar
• Arroba AI, Alcalde-Estevez E, Garcia-Ramirez M, Cazzoni D, de la Villa P, Sanchez-Fernandez EM, Mellet CO, Garcia Fernandez JM, Hernandez C, Simo R, et al. Modulation of microglia polarization dynamics during diabetic retinopathy in db/db mice. Biochim Biophys Acta. 2016;1862(9):1663–74. doi:10.1016/j.bbadis.2016.05.024.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang F, Lu F, Xu S, Hu W, Huang J, Gu Q, Sun X. The antiangiogenic effects of integrin alpha5beta1 inhibitor (ATN-161) in vitro and in vivo. Invest Ophthalmol Vis Sci. 2011;52(10):7213–20. doi:10.1167/iovs.10-7097.
   PubMed Web of Science ®Google Scholar
• Schubert HD. Cystoid macular edema: the apparent role of mechanical factors. Prog Clin Biol Res. 1989;312:277–91.
   PubMedGoogle Scholar
• Ly A, Yee P, Vessey KA, Phipps JA, Jobling AI, Fletcher EL. Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress, and neuronal functional loss. Invest Ophthalmol Vis Sci. 2011;52(13):9316–26. doi:10.1167/iovs.11-7879.
   PubMed Web of Science ®Google Scholar
• Abu El Asrar AM, Maimone D, Morse PH, Gregory S, Reder AT. Cytokines in the vitreous of patients with proliferative diabetic retinopathy. Am J Ophthalmol. 1992;114(6):731–36. doi:10.1016/S0002-9394(14)74052-8.
   PubMed Web of Science ®Google Scholar
• Yuuki T, Kanda T, Kimura Y, Kotajima N, Tamura J, Kobayashi I, Kishi S. Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy. J Diabetes Complications. 2001;15(5):257–59. doi:10.1016/S1056-8727(01)00155-6.
   PubMed Web of Science ®Google Scholar
• Patel J. Diabetes: managing dyslipidaemia. BMJ Clin Evid. 2008;2008:pii: 0610.
   PubMedGoogle Scholar
• Wilkinson-Berka JL, Fletcher EL. Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathy. Curr Pharm Des. 2004;10(27):3313–30. doi:10.2174/1381612043383179.
   PubMed Web of Science ®Google Scholar
• Curtis TM, Gardiner TA, Stitt AW. Microvascular lesions of diabetic retinopathy: clues towards understanding pathogenesis? Eye (Lond). 2009;23(7):1496–508. doi:10.1038/eye.2009.108.
   PubMed Web of Science ®Google Scholar
• Hainsworth DP, Katz ML, Sanders DA, Sanders DN, Wright EJ, Sturek M. Retinal capillary basement membrane thickening in a porcine model of diabetes mellitus. Comp Med. 2002;52:523–29.
   PubMed Web of Science ®Google Scholar
• Chronopoulos A, Trudeau K, Roy S, Huang H, Vinores SA, Roy S. High glucose-induced altered basement membrane composition and structure increases trans-endothelial permeability: implications for diabetic retinopathy. Curr Eye Res. 2011;36(8):747–53. doi:10.3109/02713683.2011.585735.
   PubMed Web of Science ®Google Scholar
• Stitt AW, Anderson HR, Gardiner TA, Archer DB. Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments. Br J Ophthalmol. 1994;78(2):133–37. doi:10.1136/bjo.78.2.133.
   PubMed Web of Science ®Google Scholar
• Roy S, Ha J, Trudeau K, Beglova E. Vascular basement membrane thickening in diabetic retinopathy. Curr Eye Res. 2010;35(12):1045–56. doi:10.3109/02713683.2010.514659.
   PubMed Web of Science ®Google Scholar
• Thoumine O, Nerem RM, Girard PR. Changes in organization and composition of the extracellular matrix underlying cultured endothelial cells exposed to laminar steady shear stress. Lab Invest. 1995;73:565–76.
   PubMed Web of Science ®Google Scholar
• Miller CG, Budoff G, Prenner JL, Schwarzbauer JE. Minireview: fibronectin in retinal disease. Exp Biol Med (Maywood). 2017;242(1):1–7. doi:10.1177/1535370216675245.
   PubMed Web of Science ®Google Scholar
• Zhou T, Che D, Lan Y, Fang Z, Xie J, Gong H, Li C, Feng J, Hong H. Qi W and others. Mesenchymal marker expression is elevated in Muller cells exposed to high glucose and in animal models of diabetic retinopathy. Oncotarget. 2017;8(3):4582–94. doi:10.18632/oncotarget.13945.
   PubMedGoogle Scholar
• Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350(1):48–58. doi:10.1056/NEJMra021678.
   PubMed Web of Science ®Google Scholar
• Su EN, Alder VA, Yu DY, Yu PK, Cringle SJ, Yogesan K. Continued progression of retinopathy despite spontaneous recovery to normoglycemia in a long-term study of streptozotocin-induced diabetes in rats. Graefes Arch Clin Exp Ophthalmol. 2000;238(2):163–73. doi:10.1007/s004170050028.
   PubMed Web of Science ®Google Scholar
• Sone H, Kawakami Y, Okuda Y, Sekine Y, Honmura S, Matsuo K, Segawa T, Suzuki H, Yamashita K. Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes. Diabetologia. 1997;40(6):726–30. doi:10.1007/s001250050740.
   PubMed Web of Science ®Google Scholar
• Schmidt-Erfurth U, Rudolf M, Funk M, Hofmann-Rummelt C, Franz-Haas NS, Aherrahrou Z, Schlotzer-Schrehardt U. Ultrastructural changes in a murine model of graded bruch membrane lipoidal degeneration and corresponding VEGF164 detection. Invest Ophthalmol Vis Sci. 2008;49(1):390–98. doi:10.1167/IOVS.07-0227.
   PubMed Web of Science ®Google Scholar
• Joyal JS, Sun Y, Gantner ML, Shao Z, Evans LP, Saba N, Fredrick T, Burnim S, Kim JS. Patel G and others. Retinal lipid and glucose metabolism dictates angiogenesis through the lipid sensor Ffar1. Nat Med. 2016;22(4):439–45. doi:10.1038/nm.4059.
   PubMed Web of Science ®Google Scholar